NO3051026T3 - - Google Patents

Info

Publication number
NO3051026T3
NO3051026T3 NO16160669A NO16160669A NO3051026T3 NO 3051026 T3 NO3051026 T3 NO 3051026T3 NO 16160669 A NO16160669 A NO 16160669A NO 16160669 A NO16160669 A NO 16160669A NO 3051026 T3 NO3051026 T3 NO 3051026T3
Authority
NO
Norway
Application number
NO16160669A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3051026T3 publication Critical patent/NO3051026T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO16160669A 2011-10-21 2009-04-01 NO3051026T3 (US07125668-20061024-C00013.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161550148P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
NO3051026T3 true NO3051026T3 (US07125668-20061024-C00013.png) 2018-07-28

Family

ID=48136439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO16160669A NO3051026T3 (US07125668-20061024-C00013.png) 2011-10-21 2009-04-01

Country Status (18)

Country Link
US (6) US20130102487A1 (US07125668-20061024-C00013.png)
EP (2) EP2768986B1 (US07125668-20061024-C00013.png)
JP (2) JP6159727B2 (US07125668-20061024-C00013.png)
KR (2) KR101912731B1 (US07125668-20061024-C00013.png)
CN (2) CN104651521B (US07125668-20061024-C00013.png)
AU (1) AU2012356317B2 (US07125668-20061024-C00013.png)
BR (2) BR122015004941B1 (US07125668-20061024-C00013.png)
CA (1) CA2852850C (US07125668-20061024-C00013.png)
DK (2) DK2768986T3 (US07125668-20061024-C00013.png)
ES (2) ES2662401T3 (US07125668-20061024-C00013.png)
HU (2) HUE035614T2 (US07125668-20061024-C00013.png)
IN (1) IN2015DN01855A (US07125668-20061024-C00013.png)
MX (2) MX357119B (US07125668-20061024-C00013.png)
NO (1) NO3051026T3 (US07125668-20061024-C00013.png)
PL (2) PL2944700T3 (US07125668-20061024-C00013.png)
PT (2) PT2768986T (US07125668-20061024-C00013.png)
RU (2) RU2611189C2 (US07125668-20061024-C00013.png)
WO (1) WO2013093635A2 (US07125668-20061024-C00013.png)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2825522A1 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
CA2883901C (en) 2012-09-04 2023-04-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP3524694B1 (en) 2013-12-28 2020-07-15 Guardant Health, Inc. Methods and systems for detecting genetic variants
EP3108012A4 (en) 2014-02-18 2017-10-11 Baylor Research Institute Mir-320e and colorectal cancer
EP3971299A3 (en) * 2014-06-13 2022-06-29 Toray Industries, Inc. Colorectal cancer detection kit or device, and detection method
WO2016034715A2 (fr) * 2014-09-05 2016-03-10 Prestizia Methode de prediction de l'evolution clinique du cancer colorectal
CN104313142B (zh) * 2014-10-16 2016-02-03 上海交通大学医学院附属仁济医院 miRNA-30a作为标记分子在制备诊断试剂中的用途
CN104388541B (zh) * 2014-10-21 2017-07-04 复旦大学附属肿瘤医院 miR‑1914*和miR‑1915的用途
CN104372004B (zh) * 2014-12-04 2018-04-27 广东医学院 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用
EP3147370A1 (en) * 2015-09-28 2017-03-29 Rheinische Friedrich-Wilhelms-Universität Bonn Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat)
WO2017106768A1 (en) 2015-12-17 2017-06-22 Guardant Health, Inc. Methods to determine tumor gene copy number by analysis of cell-free dna
EP3529376A4 (en) * 2016-08-18 2020-08-12 Nham Tran BIOMARKERS FOR ORAL, PHARYNX AND THROAT CANCER
EP3327135A1 (en) * 2016-11-28 2018-05-30 Advanced Marker Discovery, S.L. In vitro method for identifying colorectal adenomas or colorectal cancer
CN106950370A (zh) * 2017-01-25 2017-07-14 上海市第十人民医院 血液微小核酸大肠癌诊断分子组合
CN107254522A (zh) * 2017-06-09 2017-10-17 中山大学附属第三医院 miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用
CN107236799B (zh) * 2017-06-15 2020-06-09 昆明医科大学第六附属医院 一种肾纤维化miRNA标记物
CN107326092B (zh) * 2017-08-25 2021-07-20 深圳市恩普电子技术有限公司 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒
CN107746886B (zh) * 2017-09-11 2019-10-01 朱伟 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用
WO2019144183A1 (en) * 2018-01-23 2019-08-01 La Trobe University Biomarkers of colorectal cancer
EP3752645A4 (en) 2018-02-14 2022-04-13 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES IN NON-MELANOMA SKIN CANCERS
CN110205367B (zh) * 2018-02-28 2022-06-21 伽蓝(集团)股份有限公司 一种筛选保护皮肤细胞端粒的活性物的方法
KR20210031640A (ko) * 2018-05-09 2021-03-22 덤테크, 인크. 신규한 유전자 분류자 및 자가면역 질환에서의 이의 용도
CN108753974B (zh) * 2018-06-27 2022-05-06 深圳华大生命科学研究院 一种结直肠癌肿瘤标志物及其检测方法与装置
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
KR102275465B1 (ko) * 2019-01-18 2021-07-09 사회복지법인 삼성생명공익재단 전이성 대장암 치료물질 스크리닝 방법
US20220145398A1 (en) * 2019-03-11 2022-05-12 The Chinese University Of Hong Kong Mirna markers for colorectal cancer
CN110438227A (zh) * 2019-07-29 2019-11-12 广州中昱医学生物科技有限公司 miR-17-92在结直肠癌诊断中的用途
CN112080568A (zh) * 2020-09-27 2020-12-15 扬州大学 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用
WO2023032452A1 (ja) * 2021-08-31 2023-03-09 国立大学法人大阪大学 2型糖尿病・大腸がんを検査する方法
WO2023036266A1 (en) * 2021-09-08 2023-03-16 Guangdong Jiyin Biotech Co. Ltd Compositions and methods for diagnosing colorectal cancer
CN113981096A (zh) * 2021-11-30 2022-01-28 无锡市疾病预防控制中心 一种用于诊断结直肠癌的血浆miRNA标志物及其应用
WO2023222927A2 (en) 2022-05-20 2023-11-23 Novigenix Sa Biomarkers for colorectal neoplasia

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
GB0415277D0 (en) * 2004-07-07 2004-08-11 Colonix Ltd Apparatus and method for sampling mucosal surfaces
US7939255B2 (en) 2006-07-03 2011-05-10 Catholic University Industry Academy Cooperation Foundation Diagnostic methods for colorectal cancer
WO2008055158A2 (en) * 2006-10-30 2008-05-08 University Of South Alabama Microrna as biomarker in cancer
US8252538B2 (en) 2006-11-01 2012-08-28 The Ohio State University MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
JP2011501966A (ja) * 2007-10-30 2011-01-20 ベリデックス・エルエルシー 結腸直腸癌監視のためのプロセス
CN101424640B (zh) * 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
BRPI0911972A2 (pt) * 2008-05-16 2019-09-24 Veridex Llc métodos para avaliação de câncer colorretal e composições para o uso dos mesmos
WO2010004562A2 (en) 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
EP3181705A1 (en) * 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
US9074206B2 (en) * 2008-11-13 2015-07-07 Fudan University Compositions and methods for micro-RNA expression profiling of colorectal cancer
WO2010126355A1 (en) * 2009-04-29 2010-11-04 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
US20100317533A1 (en) 2009-06-05 2010-12-16 British Columbia Cancer Agency Branch Biomarkers of cancer metastasis
WO2011012136A1 (en) 2009-07-28 2011-02-03 Exiqon A/S A method for classifying a human cell sample as cancerous
CN101988060A (zh) * 2009-07-30 2011-03-23 江苏命码生物科技有限公司 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片
US8956817B2 (en) * 2009-10-09 2015-02-17 Baylor Research Institute Identification of microRNAs (miRNAs) in fecal samples as biomarkers for gastroenterological cancers
WO2011076147A1 (en) 2009-12-24 2011-06-30 Fudan University Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer
WO2011076142A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
WO2011088226A2 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings Detection of gastrointestinal disorders
US20110318742A1 (en) * 2010-06-23 2011-12-29 The Chinese University Of Hong Kong Micro rna markers for colorectal cancer

Also Published As

Publication number Publication date
JP6159727B2 (ja) 2017-07-05
US20150087525A1 (en) 2015-03-26
PT2768986T (pt) 2018-10-23
HUE035614T2 (en) 2018-05-28
CN104651521A (zh) 2015-05-27
BR122015004941B1 (pt) 2021-09-28
AU2012356317A1 (en) 2014-05-15
MX2014004810A (es) 2014-11-25
JP2015128442A (ja) 2015-07-16
KR20140097195A (ko) 2014-08-06
ES2688693T3 (es) 2018-11-06
HUE039522T2 (hu) 2019-01-28
EP2768986B1 (en) 2018-06-27
EP2944700A1 (en) 2015-11-18
RU2014120427A (ru) 2015-11-27
MX357119B (es) 2018-06-27
US20150176082A1 (en) 2015-06-25
CA2852850A1 (en) 2013-06-27
RU2662975C1 (ru) 2018-07-31
DK2944700T3 (en) 2018-01-22
WO2013093635A3 (en) 2013-09-06
PT2944700T (pt) 2018-01-24
CA2852850C (en) 2020-07-28
ES2662401T3 (es) 2018-04-06
RU2611189C2 (ru) 2017-02-21
CN104145024A (zh) 2014-11-12
JP2014530619A (ja) 2014-11-20
PL2768986T3 (pl) 2018-12-31
KR101912731B1 (ko) 2018-10-29
BR112014009643A2 (pt) 2017-12-12
JP6203209B2 (ja) 2017-09-27
CN104651521B (zh) 2021-08-27
IN2015DN01855A (US07125668-20061024-C00013.png) 2015-07-10
EP2944700B1 (en) 2017-10-18
US20130102487A1 (en) 2013-04-25
US20180346996A1 (en) 2018-12-06
BR122015004941A2 (pt) 2019-08-20
BR112014009643B1 (pt) 2020-12-15
US20180355439A1 (en) 2018-12-13
AU2012356317B2 (en) 2016-04-07
KR20150036804A (ko) 2015-04-07
DK2768986T3 (en) 2018-09-10
US20160289771A1 (en) 2016-10-06
WO2013093635A2 (en) 2013-06-27
KR101900872B1 (ko) 2018-09-20
MX357550B (es) 2018-07-13
EP2768986A2 (en) 2014-08-27
PL2944700T3 (pl) 2018-05-30

Similar Documents

Publication Publication Date Title
BR112012012396A2 (US07125668-20061024-C00013.png)
BR112012008267A2 (US07125668-20061024-C00013.png)
BR112012003062A2 (US07125668-20061024-C00013.png)
BR112012008195A2 (US07125668-20061024-C00013.png)
BRPI0925311A2 (US07125668-20061024-C00013.png)
BRPI0924307A2 (US07125668-20061024-C00013.png)
BR122021004633A2 (US07125668-20061024-C00013.png)
BR112012003080A2 (US07125668-20061024-C00013.png)
BR122017024704A2 (US07125668-20061024-C00013.png)
BR112012012487A2 (US07125668-20061024-C00013.png)
BR112012000665A2 (US07125668-20061024-C00013.png)
BR112012003853A2 (US07125668-20061024-C00013.png)
BR112012012080A2 (US07125668-20061024-C00013.png)
BR112012009797A2 (US07125668-20061024-C00013.png)
BR112012009446A2 (US07125668-20061024-C00013.png)
BR112012009703A2 (US07125668-20061024-C00013.png)
BR112012010357A2 (US07125668-20061024-C00013.png)
BR112012007656A2 (US07125668-20061024-C00013.png)
BR122019005883A2 (US07125668-20061024-C00013.png)
BR112012002627A2 (US07125668-20061024-C00013.png)
BR112012001263A2 (US07125668-20061024-C00013.png)
BR112012000159A2 (US07125668-20061024-C00013.png)
BR112012014856A2 (US07125668-20061024-C00013.png)
BRPI0924534A2 (US07125668-20061024-C00013.png)
BR112012007654A2 (US07125668-20061024-C00013.png)